Cargando…

Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction

BACKGROUND: Sugammadex, a γ-cyclodextrin derivative, belongs to a new class of selective relaxant binding agents. Sugammadex was approved 10-years ago by the European medicines agency and today is used in clinical anesthesia and emergency medicine globally. In this review, indications for neuromuscu...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Hans D, Carlos, Ricardo V, Brull, Sorin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220468/
https://www.ncbi.nlm.nih.gov/pubmed/30400850
http://dx.doi.org/10.1186/s12871-018-0605-6